Announcement on Voluntary Disclosure of the Proposed Selection of Partial Products in the National Continuation Drug Procurement

About this update from Brightgene Bio-medical Technology Co. Ltd. Class A

Announcement on Voluntary Disclosure of the Proposed Selection of Partial Products in the National Continuation Drug Procurement The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Brightgene Bio-medical Technology Co. Ltd. Class A